Profil UNITED CUTE UNICORNSProfil Katya Tsygankova

Pitch deck | Pharma & Healthcare

Více vlastníků
•
hiv investment presentation investor medicine pitch deck presentation red
hiv investment presentation investor medicine pitch deck presentation red
hiv investment presentation investor medicine pitch deck presentation red
hiv investment presentation investor medicine pitch deck presentation red
hiv investment presentation investor medicine pitch deck presentation red
hiv investment presentation investor medicine pitch deck presentation red
Pitch deck | Pharma & Healthcare
Vydáno:
Profil UNITED CUTE UNICORNSProfil Katya Tsygankova
Více vlastníků

Vlastníci

Profil UNITED CUTE UNICORNS
London, United Kingdom
Profil Katya Tsygankova
London, United Kingdom

Projekt byl vytvořen pro

profil uživatele
UCU design

Pitch deck | Pharma & Healthcare

The Israeli startup. KILLEVIR’s molecular biologists 
introduce unique anti-HIV mono-therapy drug, 
based on by Fullerene-poly-aminocaproic acid. Další informace

Vydáno:

Nástroje

Tvůrčí oblasti